Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

…, M Aringer, M Bergman, N Betteridge… - Annals of the …, 2016 - ard.bmj.com
… Neil Betteridge11, … from many regions of the world (Australia, Europe, Japan, Latin America
and North America), 5 patient representatives who had either been already involved in the …

Consensus statement on the use of rituximab in patients with rheumatoid arthritis

…, P Emery, FC Breedveld, N Betteridge… - Annals of the …, 2007 - ard.bmj.com
A large number of experts experienced in the treatment of rheumatoid arthritis were involved
in formulating a consensus statement on the use of B cell-targeted treatment with rituximab …

Self-management of rheumatic diseases: state of the art and future perspectives

MD Iversen, A Hammond, N Betteridge - Annals of the rheumatic …, 2010 - ard.bmj.com
Self-management interventions are patient-centred and designed to foster active participation
of patients in order to promote well-being and to manage symptoms. Over the past two …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

…, M De Wit, D Aletaha, N Betteridge… - Annals of the …, 2014 - ard.bmj.com
In this article, the 2010 European League against Rheumatism (EULAR) recommendations
for the management of rheumatoid arthritis (RA) with synthetic and biological disease-…

[HTML][HTML] European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

…, S Oliver, D Aletaha, N Betteridge… - Annals of the …, 2016 - ard.bmj.com
Background Since the publication of the European League Against Rheumatism recommendations
for the pharmacological treatment of psoriatic arthritis (PsA) in 2012, new evidence …

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

…, D Aletaha, X Baraliakos, N Betteridge… - Annals of the …, 2018 - ard.bmj.com
… At the beginning of this endeavour, a steering committee (SC) comprising rheumatologists
from Europe and North America experienced in SpA clinical research, a patient and a health …

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

…, M De Wit, X Baraliakos, N Betteridge… - Annals of the …, 2014 - ard.bmj.com
… initial task force expanded by consideration of a more international scope to also include
experts from Latin America and Asia, aside from previous participants from Europe and North

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

MH Buch, JS Smolen, N Betteridge… - Annals of the …, 2011 - ard.bmj.com
Background Since initial approval for the treatment of rheumatoid arthritis (RA), rituximab has
been evaluated in clinical trials involving various populations with RA. Information has also …

EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing …

M Dougados, N Betteridge, GR Burmester… - Annals of the …, 2004 - ard.bmj.com
N Betteridge2, … Downs SH, Black N. The feasibility of creating a checklist for the assessment
of the methodological quality both of randomised and non-randomised studies of health care …

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory …

…, TK Kvien, M Murakami, N Betteridge… - Annals of the …, 2013 - ard.bmj.com
Background Since approval of tocilizumab (TCZ) for treatment of rheumatoid arthritis (RA)
and juvenile idiopathic arthritis (JIA), interleukin 6 (IL-6) pathway inhibition was evaluated in …